Replies to post #7474 on Aurinia Pharmaceuticals Inc (AUPH)

[biotech_researcher]

This is not the AMRN board...

[LivingTheDream]

Lol it's ok, just happy for anyone making some good money. Sounds like he did very well and that's great.

[north40000]

I did quite awhile ago, all because of the results I was having from an off-label scrip first dosed in April 2013---recall the DES discussions among other things. Of course, DES treatment was not a named primary, or secondary or tertiary indication in the R-I clinical trial.